Enanta outlines 2026 milestones for RSV and immunology programs
Go back to Enanta outlines 2026 milestones for RSV and immunology programs| ENANTA PHARM (NASDAQ: ENTA) | Delayed: 13.30 +0.47 (3.66%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $12.83 | 52 Week High | $34.49 | |||
| Open | $12.80 | 52 Week Low | $20.39 | |||
| Day High | $13.42 | P/E | N/A | |||
| Day Low | $12.80 | EPS | $-3.18 | |||
| Volume | 196,631 | |||||

